里昂:维持京东健康(06618)“跑赢大市”评级 目标价40港元

智通财经网
Yesterday

智通财经APP获悉,里昂发布研报称,维持京东健康(06618)“跑赢大市”评级,目标价40港元。该行料公司今年收入增长加快至15%,预测京东健康去年下半年业绩稳固,收入同比升13%至297亿元人民币,受惠“双十一”良好表现,药物需求仍然强劲,受惠毛利率扩张,经调整EBIT料同比升23%至12亿元人民币。

该行料公司去年下半年直接销售同比升12%至253亿元人民币,其中第四季同比升11%,年活跃用户料较上半年增加900万至1.9亿。药物销售料继续跑赢非药物销售,因前者较不受宏观影响。公司在药物销售市占进一步增长,政府推动线上线下同价或推动“格价”,有利线上销售。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10